Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Duffull

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Journal of Biopharmaceutical Statistics|December 7, 2006
Optimal crossover designs for logistic regression models in pharmacodynamicsT H Waterhouse, J A Eccleston, S B Duffull
European Journal of Clinical Pharmacology|June 24, 1999
Development of a general method of limited sampling for the determination of AUC for a drug that displays two-compartment pharmacokineticsS B Duffull, E J Begg, J J Deely
British Journal of Clinical Pharmacology|June 1, 1995
A suggested approach to once-daily aminoglycoside dosingE J Begg, M L Barclay, S B Duffull
Antimicrobial Agents and Chemotherapy|April 1, 1997
Once-daily aminoglycoside therapy: potential ototoxicityC M Kirkpatrick, S B Duffull, E J Begg
Journal of Clinical Pharmacology|November 1, 1996
Fluoxetine distribution in human milkS B Duffull, E J Begg, K F Ilett
Journal of Pharmacokinetics and Pharmacodynamics|February 19, 2009
Simultaneous versus sequential optimal design for pharmacokinetic-pharmacodynamic models with FO and FOCE considerationsJ M McGree, J A Eccleston, S B Duffull
Journal of Biopharmaceutical Statistics|July 9, 2008
Compound optimal design criteria for nonlinear modelsJ M McGree, J A Eccleston, S B Duffull
BMJ (Clinical Research Ed.)|August 24, 1996
Single or multiple daily doses of aminoglycosides. Exposure to aminoglycosides should be monitored during treatmentE J Begg, S B Duffull, C M Kirkpatrick
British Journal of Clinical Pharmacology|February 1, 1997
Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimensS B Duffull, C M Kirkpatrick, E J Begg
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
An approach for identifiability of population pharmacokinetic-pharmacodynamic modelsV Shivva, J Korell, I G Tucker, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Journal of Biopharmaceutical Statistics|December 7, 2006
Optimal crossover designs for logistic regression models in pharmacodynamicsT H Waterhouse, J A Eccleston, S B Duffull
European Journal of Clinical Pharmacology|June 24, 1999
Development of a general method of limited sampling for the determination of AUC for a drug that displays two-compartment pharmacokineticsS B Duffull, E J Begg, J J Deely
British Journal of Clinical Pharmacology|June 1, 1995
A suggested approach to once-daily aminoglycoside dosingE J Begg, M L Barclay, S B Duffull
Antimicrobial Agents and Chemotherapy|April 1, 1997
Once-daily aminoglycoside therapy: potential ototoxicityC M Kirkpatrick, S B Duffull, E J Begg
Journal of Clinical Pharmacology|November 1, 1996
Fluoxetine distribution in human milkS B Duffull, E J Begg, K F Ilett
Journal of Pharmacokinetics and Pharmacodynamics|February 19, 2009
Simultaneous versus sequential optimal design for pharmacokinetic-pharmacodynamic models with FO and FOCE considerationsJ M McGree, J A Eccleston, S B Duffull
Journal of Biopharmaceutical Statistics|July 9, 2008
Compound optimal design criteria for nonlinear modelsJ M McGree, J A Eccleston, S B Duffull
BMJ (Clinical Research Ed.)|August 24, 1996
Single or multiple daily doses of aminoglycosides. Exposure to aminoglycosides should be monitored during treatmentE J Begg, S B Duffull, C M Kirkpatrick
British Journal of Clinical Pharmacology|February 1, 1997
Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimensS B Duffull, C M Kirkpatrick, E J Begg
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
An approach for identifiability of population pharmacokinetic-pharmacodynamic modelsV Shivva, J Korell, I G Tucker, et al.
Pageof 7